Article

Aspirin for primary prevention of CVD: Are the right people using it?

Publish date: September 4, 2013
PDF Download

 

CORRESPONDENCE Jeffrey J. VanWormer, PhD, Epidemiology Research Center, Marshfield Clinic Research Foundation, 1000 North Oak Avenue, Marshfield, WI 54449; vanwormer.jeffrey@mcrf.mfldclin.edu

The Journal of Family Practice ©2012 Quadrant HealthCom Inc.

Pages

Recommended Reading

Policy statement outlines components of successful stroke care
MDedge Family Medicine
PCI in noninfarct coronaries helps STEMI patients
MDedge Family Medicine
Prasugrel pretreatment ups bleeding risk in NSTE ACS
MDedge Family Medicine
TASTE: Thrombus aspiration has no mortality benefit in STEMI
MDedge Family Medicine
Saxagliptin, alogliptin show cardiovascular safety in randomized trials
MDedge Family Medicine
High-dose, high-potency statins reduced dementia risk
MDedge Family Medicine
Aliskiren fails to fight coronary atherosclerosis
MDedge Family Medicine
Edoxaban pivotal trial shows VTE efficacy, safety
MDedge Family Medicine
Undetected silent AF is present in 3% of 75-year-olds
MDedge Family Medicine
Cardiovascular ‘polypill’ improved medication adherence, hypertension
MDedge Family Medicine